Vetoquinol Universal Registration Document 2019

2.1 A STRATEGY ENCOMPASSING CORPORATE SOCIAL RESPONSIBILITY (CSR) 29 2.2 VETOQUINOL’S SUSTAINABLE DEVELOPMENT GOALS 29 2.3 OVERALL HEALTH, SAFETY AND ENVIRONMENTAL POLICY 32 2.3.1 HSE department structure within the Group 33 2.3.2 Development of internal HSE standards 33 2.3.3 Control of HSE risks at the core of our business 33 2.4 VETOQUINOL’S PEOPLE 34 2.4.1 Headcount analysis at December 31, 2019 35 2.4.2 Health and safety in the workplace 38 2.4.3 Attractiveness as an employer 40 2.4.4 Recruitment, induction and compensation 41 2.4.5 Organization of staff dialog 42 2.4.6 Training 43 2.4.7 Non-discrimination and equal opportunities 44 2.4.8 Work organization 44 2.5 CARBON FOOTPRINT 45 2.5.1 Prevention of pollution 45 2.5.2 Waste management 46 2.5.3 Atmospheric emissions and climate change 47 2.5.4 Protection of biodiversity 47 2.6 OUR PRODUCTS 48 2.6.1 Overview of the R&D process 48 2.6.2 Vetoquinol Group R&D strategy 49 2.6.3 Organization of Vetoquinol’s scientific division 50 2.6.4 Overview of current R&D programs 51 2.6.5 Risk of dependence on human health research to develop newmolecules 51 2.6.6 Antibiotics for veterinary use and antibioresistance: commitment to the rational use of antibiotics in animal health 52 2.6.7 Eco-friendly products 52 2.7 SOCIAL FOOTPRINT 53 2.7.1 Territorial, economic and social impact of the Group’s business 53 2.7.2 Humans and animals: a lifelong relationship 54 2.7.3 Ethics and fair practices 54 2.7.4 Supplier relations 55 2.8 AUDITOR’S REPORT 56 2 STATEMENT OF NON-FINANCIAL PERFORMANCE Vetoquinol  Universal Registration Document 2019  Financial report   27